Se enhances resistance of mouse principal hepatocytes to acetaminophen toxicity. Exp Biol Med (Maywood) 2006, 231:54552. 17. Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U, Lucius R: Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in vitro model of brain inflammation. J Neuroinflammation 2010, 7:30. 18. Zhu JH, Chen CL, Flavahan S, Harr J, Su B, Flavahan NA: Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3. Am J Physiol Heart Circ Physiol 2011, 300:H1770 1780. 19. Kim SH, Smith CJ, Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 2004, 25:43139. 20. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320330. 21. Kaushal V, Schlichter LC: Mechanisms of microglia-mediated neurotoxicity in a new model in the stroke penumbra. J Neurosci 2008, 28:2221230. 22. Novarino G, Fabrizi C, Tonini R, Denti MA, Malchiodi-Albedi F, Lauro GM, Sacchetti B, Paradisi S, Ferroni A, Curmi PM, Breit SN, Mazzanti M: Involvement of your intracellular ion channel CLIC1 in microglia-mediated beta-amyloidinduced neurotoxicity. J Neurosci 2004, 24:5322330. 23. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS: Numerous neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978, 38:3751757. 24. Farooqui SM: Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sci 1994, 55:1887893. 25. Tambuyzer BR, Ponsaerts P, Nouwen EJ: Microglia: gatekeepers of central nervous technique immunology. J Leukoc Biol 2009, 85:35270. 26. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune method subjugates the brain. Nat Rev Neurosci 2008, 9:466. 27. McAfoose J, Baune BT: Evidence for a cytokine model of cognitive function.Blebbistatin Neurosci Biobehav Rev 2009, 33:35566. 28. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, Bienfait K, Dicke A, Kusnekov A: The role of inflammatory cytokines in cognition as well as other non-motor symptoms of Parkinson’s disease. Psychosomatics 2010, 51:47479. 29. Suzuki E, Yagi G, Nakaki T, Kanba S, Asai M: Elevated plasma nitrate levels in depressive states.Erdafitinib J Influence Disord 2001, 63:22124.PMID:23376608 30. McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are optimistic for HLA-DR within the substantia nigra of Parkinson’s and Alzheimer’s illness brains. Neurology 1988, 38:1285291. 31. Gao HM, Hong JS: Why neurodegenerative diseases are progressive: uncontrolled inflammation drives illness progression. Trends Immunol 2008, 29:35765. 32. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:91518. 33. Shen S, Yu S, Binek J, Chalimoniuk M, Zhang X, Lo SC, Hannink M, Wu J, Fritsche K, Donato R, Sun GY: Distinct signaling pathways for induction of form II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int 2005, 47:29807. 34. Moss DW, Bates TE: Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 2001, 13:52938.Liu et al. Journal of Neuroinflammation 2014, 11:47 http://www.jneuroi.